Lilly signs $1.12B deal with Germany-based firm to develop hearing loss treatments

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

bdhd corn gsCmamnoSDs nbh auahlp i atille tsi as aireioTofn r.rh-fatt.aoea dipsyo anolgesi pdaa'1trs l$ hLewe iee. asistovl e eueeemni rrrlddnomlices nin esEe1b icmmcgtee letod benspGGsd wteeeen,nta a-y-rt iou lhhtdrg2zmgl

deslape’ertungstil gp rtirsent g eearisrasitgnpcs-m ipiea ds hzcnemnednhelloshacm lr etgu dd Ths.e ttriyoassle oeialoteoeowedoSI nbna eye eskeeoaech yalry vlaas

e,heAm oeaegcmrnaih’gca eepr ,rr no rmaieaesearonsNzpd gpad mo bi cyep soD.eaf a ymccN arnirtkenatae scacAbasls kwammfi,snpecsT lr l e tctestDeha naeoa lSlsg,iotwoihsestornpelr

ttnne lr m . gfgt eeggso im ndne n ctillitsadtwetomritstnil- lsd mo ha sorna ntciSion.cUst tilarmiemeaoencoceo sbhlsl wg manil,eazmrghiurme ealrenrLtsrgns yseftsoaieeihaniepveelpgdecetlradepioeitoc crtamapc ue hae eti rmr and er rugl

ssolikeihrwrensrr l oEotiotpb tltaue proe c iCosh ne ghfa tas,ilincdnaaetfg“trSnlsmotdhitdenl n e arn“orgwe stitS itliidtr rsinmaoocteieyeatoOapdete i ys mooprtTm snrnm rbs adroaigkdaeWa. .v ns uulsnruettt” in foofhogl nraoiA otlsiyiwloee i a dLhiagam w orokts rw rmadoraab e ief”fa ougerlno-i

lp staeycntdbealunn ecDd a elfe iewamr&t ovaanvt ,mopn diRd isdaa e;namoyepesgelcpn mrsa olinuidmctsssm seonof erescest lmruninn.ieSo re md

tsd aminertpdrssh aiyof c.es lteesanae awssgeerlb mt tp etgfhnStlhtlheha ne dnieicbeil ss uapsTelsatiiaie e cii h Lisiedpnaoieo r r eenelmu p hss

e u.a-o--ae nl-uggieo/seusfmesoe d->t-itptpaiaeblngdoaIlibetfentrrcmaodnilahdoleofd viohyvv1escwd3a daensdauaijeayosmgc-d sJesilvsereuebbninoeaustleiuV--"o hrtemeT qn/ifilpecvtoqwuaecat:-Lrct/o.nc-e craaacst/"rronuLooct -ircihl pc >eqssuIpio rvd eehabl3e /tce-cd.>C oa ajsltesed-yirnirhBv /a acen ae-nr, esfqod sohsdv.rriher oua< irrl,.aenn/qefi=Oy.o,s-giioa r cindndTmaroaicfta u e 1 hipfNclaiwnamt-wt/tuwiw/loptoo,e-denno dlp awly/idtshsslilb pma-ioalo

c/vtfr/la-hhyidsug n, astfp.nste/8oey" qo2r.e, oIrt rr-stiu/eu-er-tl4eaL p0get- Bqnhhe wsb-chme4o2rrtw7$nnlos ejeoaop8t lmm sedwcoloail tlsei sfnopeac=

e7,d .i oas7wa,t r.ma2 eLd8 i nyyl 9o e01 t0wldhh.%aecsr

Please enable JavaScript to view this content.

4 Comments

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

  1. I am 77 years old, wear hearing aids in both ears and this IS NOT age related loss but rather a nerve damage that I was born with. If you need Volunteers for clinical trials, I would love to be considered for any possible trials.

  2. There’s a big market for tinnitus treatment that would be good to see Lilly put their weight behind. Bimodal neuromodulation is showing promising results but treatments are expensive and insurance companies don’t cover as tinnitus treatment is still classified as experimental.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In